More aggressive prostate cancer cells (PCCs) are often resistant to chemotherapy. Differences exist in redox status and mitochondrial metabolism that may help explain this phenomenon. Two human PCC lines. PC-3 cells (more aggressive) and LNCaP cells (less aggressive). https://chefesquipmenters.shop/product-category/adaptive-drinkware/